Market Closed

MYGN
Myriad Genetics
$ 5.66
-0.35%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Myriad Genetics News

Latest Myriad Genetics Stock News & MYGN Headlines

Myriad Genetics, Inc. (MYGN) Presents at 2026 UBS Global Healthcare Conference Transcript
4 days ago | seekingalpha.com
Myriad Genetics, Inc. (MYGN) Q3 2026 Earnings Call Transcript
10 days ago | seekingalpha.com
Myriad Genetics (MYGN) Reports Q3 Loss, Beats Revenue Estimates
10 days ago | zacks.com
Myriad Genetics Q3 Earnings Call Highlights
10 days ago | marketbeat.com
Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives
10 days ago | globenewswire.com
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
12 days ago | globenewswire.com
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
a month ago | globenewswire.com
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
a month ago | globenewswire.com
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
2 months ago | globenewswire.com
This Biotech Stock Got a Rare Double-Downgrade. Its Profitability Problem Just Got Worse.
2 months ago | barrons.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MYGN
Myriad Genetics
$ 5.66
-0.35%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago